Prevalence and patterns of the concurrent use of anticholinergics for the motor symptoms of Parkinson’s disease and acetylcholinesterase inhibitors in Parkinson’s disease patients with dementia: a cross-sectional study using Korea National Health Insurance claims data

BACKGROUND: The concurrent use of anticholinergics and acetylcholinesterase inhibitors (ACHEIs) in Parkinson’s disease (PD) patients with dementia should be avoided because the opposing pharmacological actions of both drugs reduce the treatment efficacy. We aimed to investigate the prevalence of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Baik, Deborah, Yu, Yun Mi, Jung, Sun-Young, Kang, Hye-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306150/
https://www.ncbi.nlm.nih.gov/pubmed/35864474
http://dx.doi.org/10.1186/s12877-022-03296-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306150/
https://www.ncbi.nlm.nih.gov/pubmed/35864474
http://dx.doi.org/10.1186/s12877-022-03296-w

Ejemplares similares